Skip to content
AP Statistics · Exploring One-Variable Data and Collecting Data

Placebo effect

Placebo effect appears in 9 reviewed AP Statistics questions and sits in Exploring One-Variable Data and Collecting Data. Below are worked examples showing exactly how the exam tests it, with the answer marked and every distractor explained.

How Placebo effect is tested

Example 1Easier
In clinical trials, a placebo is a treatment with no active ingredient (e.g., a sugar pill). Why is including a placebo group important in testing a new drug?
  1. ATo reduce the cost of manufacturing the active drug.
  2. BTo ensure that every participant receives some treatment.
  3. CTo control for the placebo effect, where participants improve simply because they believe they are receiving treatment.Correct
  4. DTo double the sample size of the study.

Why C is right

The placebo effect occurs when patients experience real improvements in health outcomes simply because they believe they are receiving an effective treatment. Including a placebo group allows researchers to separate the actual drug effect from the placebo effect, by comparing the active treatment group to the placebo group.
Why the other 3 choices miss
A
Cost considerations are not the statistical rationale for including a placebo group. The purpose is controlling for the placebo effect.
B
In a placebo-controlled study, the placebo group receives an inactive substance, not an actual treatment. The goal is to provide a comparison baseline, not to ensure everyone benefits.
D
Including a placebo group increases total sample size but the purpose is not simply size inflation. The scientific purpose is to isolate the drug effect.
Example 2Easier
In a double-blind randomized clinical trial for a new drug, both 'blinding' elements refer to:
  1. AThe drug is administered in two doses that neither patients nor doctors know about.
  2. BTwo separate clinical teams independently analyze the data without communicating.
  3. CThe patients are unaware of their treatment, and the researchers analyzing data are unaware of treatment assignments.Correct
  4. DThe control group receives no treatment, and both groups are unaware of their assignment.

Why C is right

In a double-blind trial, two groups are blinded: (1) Subjects/patients do not know whether they receive the treatment or placebo — preventing the placebo effect from biasing results. (2) Researchers and clinicians administering and evaluating treatments do not know which group received which treatment — preventing observer bias. Both forms of bias can distort outcomes in ways that favor the treatment, which is why double-blinding is considered the gold standard for clinical trials.
Why the other 3 choices miss
A
Incorrect. 'Double-blind' refers to who is blinded (subjects and researchers), not to the dose structure. Two doses are not part of the definition of a double-blind trial.
B
Incorrect. Independent analysis teams are part of some research integrity procedures but are not what 'double-blind' means. Double-blind refers to blinding of subjects and researchers/evaluators, not independent teams.
D
Incorrect. A control group receiving no treatment (or a placebo) is a feature of controlled trials in general, not specifically of double-blinding. Double-blinding specifically refers to who is unaware of treatment status.

Studied alongside

Other concepts from Exploring One-Variable Data and Collecting Data.